Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Pharmacokinetics of QAW039 in Steroid-free Patients With Mild to Moderate Persistent Asthma.

Next Previous
Trial Profile

A Randomized, Placebo-controlled, Parallel Group Study to Assess the Efficacy, Safety, and Pharmacokinetics of QAW039 in Steroid-free Patients With Mild to Moderate Persistent Asthma.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 27 Aug 2014

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fevipiprant (Primary) ; Fluticasone propionate (Primary)
  • Indications Allergic asthma
  • Focus Pharmacogenomic; Therapeutic Use
  • Sponsors Novartis Pharmaceuticals

Most Recent Events

  • 30 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
  • 17 Mar 2012 Additional trial locations (Bulgaria, Hungary, Poland) added as reported by European Clinical Trials Database.
  • 17 Mar 2012 This trial is recruiting in Belgium, Hungary and has been discontinued in Germany, Bulgaria and completed in Poland.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top